Constant (vaccination)
|
Mean
|
-3.18
|
***a
|
(-4.50 to -1.86)
|
|
S.D.
|
9.26
|
***
|
(7.62 to 10.9)
|
Degree of protection against cervical cancer (per 10%)
|
Mean
|
1.18b
|
***
|
(0.99 to 1.36)
|
|
S.D.
|
0.75
|
***
|
(0.60 to 0.90)
|
Duration of protection 6 years (omitted)c
|
Mean
|
-2.37
|
***
|
(-2.72 to -2.03)
|
|
S.D.
|
1.46
|
***
|
(1.41 to 1.51)
|
Duration of protection 25 years
|
Mean
|
0.56
|
***
|
(0.40 to 0.72)
|
|
S.D.
|
0.36
|
***
|
(0.10 to 0.62)
|
Duration of protection lifetime
|
Mean
|
1.81
|
***
|
(1.51 to 2.11)
|
|
S.D.
|
1.42
|
***
|
(1.14 to 1.70)
|
1/750,000 risk of serious side effects (omitted)c
|
Mean
|
3.04
|
***
|
(2.54 to 3.55)
|
|
S.D.
|
3.18
|
***
|
(2.98 to 3.38)
|
1/150,000 risk of serious side effects
|
Mean
|
0.62
|
***
|
(0.37 to 0.86)
|
|
S.D.
|
0.70
|
***
|
(0.42 to 0.98)
|
1/30,000 risk of serious side effects
|
Mean
|
-3.66
|
***
|
(-3.06 to -4.25)
|
|
S.D.
|
3.11
|
***
|
(2.45 to 3.77)
|
Vaccination at age 9 years (omitted)c
|
Mean
|
-0.65
|
***
|
(-0.86 to -0.44)
|
|
S.D.
|
0.32
|
***
|
(0.30 to 0.33)
|
Vaccination at age 12 years
|
Mean
|
0.11
| |
(-0.06 to 0.29)
|
|
S.D.
|
0.29
|
***
|
(0.10 to 0.48)
|
Vaccination at age 14 years
|
Mean
|
0.54
|
***
|
(0.36 to 0.72)
|
|
S.D.
|
0.29
|
***
|
(0.10 to 0.48)
|
Model fits
| | | | |
Log-Likelihood function
| | |
-1205.62
| |
Akaike information criterion
| | |
0.93
| |
Bayesian information criterion
| | |
0.96
| |
Pseudo R-squared
| | |
0.58
| |